Determination of soluble HLA-G serum levels in patients with adenomyosis and uterine fibroids before and after surgery
article
OA: closed
CC0
⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study measured serum levels of soluble HLA-G in patients with adenomyosis and uterine fibroids before and after surgical intervention.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (48)
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis via openalex
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Diagnosis, Evaluation, and Treatment of Adenomyosis via openalex
- HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium via openalex
- HLA-G is upregulated in advanced endometriosis via openalex
- Immunological changes associated with adenomyosis: a systematic review via openalex
- Is adenomyosis an immune disease? via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Pathology and Pathogenesis of Adenomyosis via openalex
- Possible roles of HLA-G regulating immune cells in pregnancy and endometrial diseases via KIR2DL4 via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- W2093086630 via openalex
- W2158829408 via openalex
- W2166126168 via openalex
- W2247608889 via openalex
- W2322993062 via openalex
- W2340310656 via openalex
- W2462539656 via openalex
- W2495162923 via openalex
- W2594354909 via openalex
- W2768159192 via openalex
- W2805752195 via openalex
- W2946528781 via openalex
- W2962926982 via openalex
- W3015765529 via openalex
- W3017874366 via openalex
- W3177797707 via openalex
- W3209230215 via openalex
- W4205715480 via openalex
- W4210313848 via openalex
- W4213314835 via openalex
- W4294266907 via openalex
- W6776283671 via openalex
- W6785042710 via openalex
- W6805894638 via openalex
- W6807680256 via openalex
- W1970410047 via openalex
- W6842675402 via openalex
- W1986672594 via openalex
- W1989173653 via openalex
- W2002220805 via openalex
- W2021902701 via openalex
- W2023923460 via openalex
- W2029488286 via openalex
- W2029675712 via openalex
- W2031509003 via openalex
- W2046788012 via openalex
- W2048332030 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:33:56.134770+00:00
License: CC0
· commercial use OK